Global clinical trials are no longer optional, they are a necessity. Expanding trials across regions accelerates patient recruitment and improves diversity, but it also introduces significant complexity in data management and regulatory compliance. Each geography comes with its own regulatory framework, data privacy laws, and operational nuances. Without a centralized approach, sponsors and CROs often […]

The Real Problem: Scale Breaks Traditional Systems Managing a handful of trials is a coordination exercise. Managing 50+ trials simultaneously is a systems problem. At scale, CROs face compounding inefficiencies: Traditional EDC and eTMF platforms were not designed for this level of concurrency. They rely heavily on human intervention, retrospective validation, and fragmented workflows. AI-powered […]

Phase 3 clinical trials are the most complex, expensive, and data-intensive stage of drug development. They involve thousands of patients, multiple countries, strict regulatory oversight, and tight timelines. Managing such scale with disconnected systems is a recipe for inefficiency. That’s why sponsors and CROs are increasingly adopting integrated eClinical platforms that unify EDC and CTMS. […]